|
191. (Journal Article): C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor-rats.
Stevens MJ, Zhang W, Li F, Sima AAF ABSTRACT:
Oxidative stress and neurovascular dysfunction have emerged as contributing factors to the development of experimental diabetic neuropathy (EDN) in streptozotocin-diabetic rodents....
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Neural
»
Journal Article
submitted: Mar 09, 2006 |
|
192. (Journal Article): Measurement of renal function by calculation of fractional uptake of technetium-(99m) dimercaptosuccinic acid
Beatovic SLj, Jaksic ED, Han RS ABSTRACT:
BACKGROUND: The purpose of this study was to set up normal values of the fractional uptake (FU) of technetium-(99m) dimercaptosuccinic acid in adults and in the pediatric populatio...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Renal
»
Journal Article
submitted: Aug 22, 2004 |
|
193. (Journal Article): Genetics of diabetic nephropathy in the Pima Indians
Imperatore G, Knowler WC, Nelson RG, Hanson RL ABSTRACT:
Diabetic nephropathy is the leading cause of renal failure in industrialized countries. There is strong evidence that diabetic nephropathy is influenced by genetic factors. Studies...
|
»
Diabetes OD
»
Diabetic Complicatio...
»
Renal
»
Genetics
»
Journal Article
submitted: Sep 22, 2004 |
|
194. (Journal Article): Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation.
Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, Ostraat O, Salmela K, Tibell A, Tufveson G, Elgue G, Nilsson Ekdahl K, Korsgren O, Nilsson B ABSTRACT:
BACKGROUND: Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis rema...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Complications
»
Intraportal Thrombos...
»
Inhibition of Thromb...
»
Blockade of Tissue F...
»
Journal Article
submitted: Jan 07, 2006 |
|
195. (Journal Article): XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury.
Emamaullee JA, Liston P, Korneluk RG, Shapiro AM, Elliott J ABSTRACT:
Recent advances in clinical islet transplantation have allowed patients with type 1 diabetes to become insulin independent, but the procedure is limited since islets from two donor...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Follow-up
»
Islet Cell Apoptosis
»
Hypoxia
»
Journal Article
submitted: Jan 07, 2006 |
|
196. (Journal Article): Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion.
Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, Thorens B ABSTRACT:
betaTC-tet cells are conditionally immortalized pancreatic beta cells which can confer long-term correction of hyperglycemia when transplanted in syngeneic streptozocin diabetic mi...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Follow-up
»
Islet Cell Apoptosis
»
Hypoxia
»
Journal Article
submitted: Jan 07, 2006 |
|
197. (Journal Article): Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.
Lopez-Talavera JC, Garcia-Ocana A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF ABSTRACT:
Islet transplantation for diabetes is limited by the availability of human islet donors. Hepatocyte growth factor (HGF) is a potent beta-cell mitogen and survival factor and improv...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Follow-up
»
Islet Cell Graft Fun...
»
Preserving and Enhan...
»
Mitogenic and Surviv...
»
Hepatocyte Growth Fa...
»
Journal Article
submitted: Jan 15, 2006 |
|
198. (Journal Article): Factors influencing Islet of Langerhans graft function and monitoring.
Pileggi A, Ricordi C, Alessiani M, Inverardi L ABSTRACT:
Transplantation of islet of Langerhans represents a viable therapeutic option for insulin-dependent diabetes mellitus. Dramatic progress has been recently reported with the introdu...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Follow-up
»
Islet Cell Graft Fun...
»
Monitoring of Islet ...
»
Journal Article
submitted: Jan 15, 2006 |
|
199. (Journal Article): The potential role of glucagon-like peptide 1 in diabetes.
Meier JJ, Nauck MA ABSTRACT:
The incretin hormone glucagon-like peptide 1 (GLP-1) has a promising potential for the treatment of type 2 diabetes due to its glucose-dependent insulinotropic and glucagonostatic ...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|
200. (Journal Article): Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.
Holst JJ ABSTRACT:
Glucagon-like peptide-1 (GLP-1) is an insulinotropic hormone secreted from endocrine cells in the gut mucosa in response to meal ingestion. It is an important incretin hormone; mic...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|